摘要
目的:探讨血液透析滤过治疗伴有高磷血症的维持性血液透析患者效果。方法:2016年3月-2019年1月收治伴有高磷血症维持性血液透析患者100例,随机分为两组,各50例。常规组给予一般治疗;血液透析组给予血液透析滤过治疗。比较两组治疗效果。结果:血液透析组治疗总有效率高于常规组,钙磷乘积及甲状旁腺素水平均高于常规组,并发症发生率低于常规组,差异均有统计学意义(P<0.05)。结论:伴有高磷血症的维持性血液透析患者实施血液透析滤过治疗效果确切,可有效降低钙磷乘积及甲状旁腺素水平,并发症发生率低。
Objective:To investigate the effect of hemodiafiltration in the treatment of maintenance hemodialysis patients with hyperphosphatemia.Methods:From March 2016 to January 2019,100 maintenance hemodialysis patients with hyperphosphatemia were enrolled,and they were radomly divided into two groups of 50 cases in each.The control group was given general treatment and the hemodialytic group was treated with hemodiafiltration.The therapeutic effects between groups was compared.Results:The total effective rate of the hemodialytic group was higher than the control group;the levels of calcium-phosphorus product and parathyrin were higher than those in the control group;the incidence of complications was lower than in the control group;the differences were statistically significant(P<0.05).Conclusion:The hemodiafiltration is effective in maintenance hemodialysis patients with hyperphosphatemia.It can effectively reduce the calcium-phosphorus product and the level of parathyrin and the incidence of complications is low.
作者
高洁
刘益涛
常相帝
张敏
Gao Jie;Liu Yitao;Chang Xiangdi;Zhang Min(Department of Nephrology,the affiliated Hospital of Binzhou Medical College,Shandong Binzhou 256600)
出处
《中国社区医师》
2020年第2期72-73,共2页
Chinese Community Doctors
